ReviR Therapeutics
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs. Its RNA therapeutics treat cancer, rare genetic disorders, and infectious diseases. It also develops an AI-based and computation-empowered platform to discover RNA-targeting therapeutics.
Domain
revirtx.com
Country
United StatesIndustry
Alternative MedicineEmployees
11-50
Last Funding
$4.6M
Founded
2020
Tech Stack (7 technologies)
Frequently Asked Questions
What technologies does ReviR Therapeutics use?+
ReviR Therapeutics uses 7 technologies including core-js, Vue.js, Webpack.
What industry is ReviR Therapeutics in?+
ReviR Therapeutics operates in the Alternative Medicine industry.
Where is ReviR Therapeutics based?+
ReviR Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026